"
Time to Progression of AFP (TPA) as a Predictor of Survival in Hepatocellular Carcinoma Treated with Sorafenib (SOR)"
written by Maria Varela, Olegario Castaño-Fernández, Marcelo Garrido, Lorena Blanco-García, Pablo Martínez-Camblor, Alicia Mesa-Álvarez, Carmen Navascués, Valle Cadahía-Rodrigo, Rafael Menéndez de Llano, Ramon Pérez-Álvarez, Maria Luisa González-Diéguez, Manuel Rodríguez,
published by
Journal of Cancer Therapy,
Vol.5 No.14, 2014
has been cited by the following article(s):
|
[1]
|
Resistance to Molecular Therapies for Hepatocellular Carcinoma
Resistance to Targeted Anti-Cancer Therapeutics,
2017
DOI:10.1007/978-3-319-56197-4_7
|
|
|
|